ArticleArthritis research & therapy2017

TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.

Octavio Aravena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.